Skip to Main Content

Paper Details

Predicted effectiveness of vaccines and extended half-life monoclonal antibodies against RSV hospitalizations in children.
NPJ Vaccines
4
2022
Author NameAffiliation
Daniel M WeinbergerYale School of Public Health, Yale University
  • 1 - 1

Datasets

Release 1.2